This study was a single-center randomized controlled trial which lasted 14 days and consisted of two stages (run-in period (stage I) and intervention period (stage II) each contain 7 days without potassium supplement. If participants meet the enrollment criteria at the end of stage I, they were assigned to the low sodium group (50mmol/d) or normal sodium group (100mmol/d), and then continued to finish stage II. The primary outcome was the change in serum potassium after exposure to normal sodium / low sodium diet and the secondary outcome was the assessment of BP change following a normal sodium / low sodium diet.
Clinical Study
Summary
Study Name: The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism
Status: Completed
Conditions: Primary aldosteronism
Interventions: Dietary Supplement: Sodium
Locations: Shanghai Jiao Tong University School of Medicine, Shanghai, China
Study link: https://clinicaltrials.gov/study/NCT05649631
To search for other studies by topic, location, or status, go to our Clinical Studies page.
